Dabigatran

5 trials 5 recruiting

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

5 Recruiting

0 Completed trials

4 Sponsors

12 Countries

Phase III

Phase IV

Phase III: 2 Phase IV: 3

Oversight events:

5 corrective measures across 1 trial

View oversight register →

Indications tested

Atrial fibrillation 2 Acute coronary syndrome 1 Chronic coronary syndrome 1 Atrial flutter 1

Sponsors using this IMP

Hamilton Health Sciences Corporation 2 Academisch Ziekenhuis Leiden 1 Insel Gruppe AG 1 Odense University Hospital 1

All trials

5 total

Treatment with a single drug that prevents blood clot formation followed by an anticoagulant drug in patients with irregular heartbeat who h… Recruiting

2023-509717-36-00 Phase III 7 countries Insel Gruppe AG
The Direct Oral Anticoagulation versus Vitamin K Antagonist after Cardiac Surgery (DANCE) Trial Recruiting

2023-504504-28-00 Phase III 1 country Hamilton Health Sciences Corporation
DISTINCT: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one size fits all’ approach in patients undergoing Total hIp or t… Recruiting

2023-510186-98-00 Phase IV 1 country Academisch Ziekenhuis Leiden
Can patients with atrial fibrillation discontinue anticoagulant therapy after cardiac surgery: The ATLAAC trial Recruiting

2022-502986-92-00 Phase IV 2 countries Odense University Hospital
Anticoagulation for Stroke Prevention In patients with Recent Episodes of Atrial Fibrillation occurring transiently with stress Recruiting

2023-509142-35-00 Phase IV 10 countries Hamilton Health Sciences Corporation

Showing 1–5 of 5 trials

← All drugs A–Z